IvanRosasMD

Pulmonology • Houston, TX

Critical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine

Physician

Join to view full profile

Dr. Rosas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosas' full profile

Already have an account?

Office
7200 Cambridge St
Houston, TX 77030
Phone+1 713-798-2400

Fax+1 713-798-2688

Education & Training

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1997
National University of ColombiaClass of 1991

Certifications & Licensure

TX State Medical License 2019 - 2024
MA State Medical License 2008 - 2021
MD State Medical License 1997 - 2013
DC State Medical License 2004 - 2008
PA State Medical License 2005 - 2008

Clinical Trials

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 Start of enrollment: 2020 Nov 18
Completed
Phase 4
Roles: Contact
Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis Start of enrollment: 2022 Sep 08
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

11 citations
Primary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications.
Lourdes Chacon-Alberty, Ramiro Fernandez, Peter Jindra, Madelyn King, Ivan Rosas
Transplantation. 2023-08-01
22 citations
microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
Farida Ahangari, Nathan L Price, Shipra Malik, Maurizio Chioccioli, Thomas Bärnthaler
JCI Insight. 2023-02-22
44 citations
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, Maureen D Mayes, Ivan O Rosas
Respiratory Research. 2023-01-09